Elevated serum adenosine deaminase levels in neuroleptic-naïve patients with recent-onset schizophrenia

Asian J Psychiatr. 2017 Oct:29:13-15. doi: 10.1016/j.ajp.2017.03.034. Epub 2017 Mar 27.

Abstract

The present study examined serum levels of adenosine deaminase (ADA), an adenosine metabolizing enzyme, in neuroleptic-naive patients with recent-onset schizophrenia and age-matched healthy comparison subjects. ADA levels were found to be higher among patients, and revealed a possible link between evening rise and severity of auditory hallucinations as well as morning rise and severity of avolition-apathy in patients with schizophrenia. These findings suggest the potential utility of serum ADA as a peripheral biomarker of schizophrenia.

Keywords: Adenosine deaminase; Avolition; Hallucination; Neuroleptic-naive; Schizophrenia.

MeSH terms

  • Adenosine Deaminase / blood*
  • Adolescent
  • Adult
  • Biomarkers / blood
  • Female
  • Hallucinations / blood*
  • Hallucinations / diagnosis
  • Humans
  • Male
  • Schizophrenia / blood*
  • Schizophrenia / diagnosis
  • Severity of Illness Index
  • Young Adult

Substances

  • Biomarkers
  • Adenosine Deaminase